Visualisation of loss of 5-HT(2A) receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging

Psychiatry Research - Neuroimaging

Volumn 68, Issue 1, 1996, Pages 11-22

  Rosier, Annemie ^a   Dupont, Patrick ^a,b   Peuskens, Jozef ^b   Bormans, Guy ^b   Vandenberghe, Rik ^a   Maes, Michael ^c   De Groot, Tjibbe ^b   Schiepers, Christiaan ^b   Verbruggen, Alfons ^b   Mortelmans, Luc ^b  

^a KU LEUVEN UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c Stuivenberg General Hospital   (Belgium)

Author keywords

5 HT(2A) receptors; altanserin; fluorine 18; in vivo; PET; serotonin

Indexed keywords

ALTANSERIN; FLUORINE 18; SEROTONIN RECEPTOR;

ADULT; AGING; ARTICLE; BRAIN CORTEX; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR LOSS;

ADULT; AGING; BRAIN; BRAIN MAPPING; CEREBRAL CORTEX; DOMINANCE, CEREBRAL; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; KETANSERIN; MALE; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; REFERENCE VALUES; SEROTONIN ANTAGONISTS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030602085     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4927(96)02806-5     Document Type: Article

References (40)

1. Äsberg, M. and Märtensson, B. (1993) Serotonin selective antidepressant drugs: past, present, future. Clin Neuropharmacol 16, S32-S44.
2. 11C-labeled ketanserin and positron tomography. Rev Neurol 141, 537-545.
3. 2 receptors in humans using positron emission tomography. Eur J Nucl Med 21, 937-946.
4. 2 receptors in Alzheimer's disease. Brain 116, 497-510.
5. 18F-setoperone studied in humans using positron emission tomography. J Neurochem 58, 2303-2310.
6. 18F]Setoperone: a new high affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo. Eur J Pharmacol 147, 73-82.
7. 18F-labeled setoperone. J Neurochem 54, 1744-1754.
8. Brown, S.L. and van Praag, H.M. (Eds.) (1991) The Role of Serotonin in Psychiatric Disorders. Brunner-Mazel, New York.
9. Carlsson, A. (1981) Aging and brain neurotransmitters. In: Platt, D. (Ed.), Funktionstörungen des Gehirns im Alter. Schattauer, Stuttgart, pp. 67-81.
10. Coppen, A.J. and Doogan, D.P. (1988) Serotonin and its place in the pathogenesis of depression. J Clin Psychiatry 49, 4-11.
11. Cross, A.J., Crow, T.J., Ferrier, I.N. and Johnson, J.A. (1986) The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia. Neurobiol Aging 7, 3-7.
12. Cross, A.J., Crow, T.J., Ferrier, I.N., Johnson, J.A., Bloom, S.R. and Corsellis, J.A.N. (1984) Serotonin receptor changes in dementia of the Alzheimer type. J Neurochem 43, 1574-1581.
13. Crouzel, C., Guillaume, M., Barré, L., Lemaire, C. and Pike, V.W. (1992) Ligands and tracers for PET studies of the 5-HT system - Current status. Nucl Med Biol 19, 857-870.
14. Crow, T.J., Cross, A.J., Cooper, S.J., Deakin, J.F.W., Ferrier, I.N., Johnson, J.A., Joseph, M.H., Owen, F., Poulter, M., Lofthouse, R., Corsellis, J.A.N., Chambers, D.R., Blessed, G., Perry, E.K., Perry, R.H. and Tomlinson, B.E. (1984) Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology 23, 1561-1569.
15. Curzon, G. (1988) Serotonergic mechanisms of depression. Clin Neuropharmacol 11, S11-S20.
16. Frost, J.J. (1990) Imaging the serotoninergic system by PET. Ann NY Acad Sci 600, 272-281.
17. Handley, S.I., McBlane, J.W., Critchley, M.A.E. and Njung'e, K. (1993) Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors. Behav Brain Res 58, 203-210.
18. Jovkar, S., Wienhard, K., Coenen, H.H., Pawlik, G. and Heiss, W.-D. (1991) Quantification of baboon cortical S2 serotonin receptors in vivo with 3-N-(2′-F18)fluoroethylspiperone and positron emission tomography. Eur J Nucl Med 18, 158-163.
19. Lemaire, C., Cantineau, R., Guillaume, M., Plenevaux, A. and Christiaens, L. (1991) Fluorine-18 altanserin: A radioligand for the study of serotonin receptors with PET: Radiolabeling and in vivo biologic behaviour in rats. J Nucl Med 32, 2266-2272.
20. 2 receptor studies. Neuropsychopharmacology 3, 361-369.
21. Leysen, J.E. and Gommeren, W. (1986) Drug-receptor dissociation time, new tool for drug research: Receptor binding affinity and drug-receptor dissociation profiles of serotonin-S2, dopamine-D2, histamine-H1 antagonists and opiates. Drug Dev Res 8, 119-131.
22. 2 receptors, roles and regulation. Ann NY Acad Sci 600, 183-193.
23. 11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 10, 7407.
24. 2 receptors in suicide victims: Violence of death, depression, and effect of antidepressant treatment. Brain Res 642, 281-289.
25. Lucki, I., Singh, A. and Kreiss, D.S. (1994) Antidepressant-like behavioral effects of serotonin receptor agonists. Neurosci Biobehav Rev 18, 85-95.
26. Maes, M. and Meltzer, H.Y. (1995) The serotonin hypothesis of major depression. In: Bloom, F.E. and Kupfer, D.J. (Eds.), Psychopharmacology, the Fourth Generation of Progress. Raven Press, New York, pp. 933-944.
27. 2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 43, 954-959.
28. Marcusson, J.O., Morgan, D.G., Winblad, B. and Finch, C.E. (1984) Serotonin-2 binding sites in human frontal cortex and hippocampus. Selective loss of S-2A sites with age. Brain Res 311, 51-56.
29. 18F]fluoroethylketanserin and PET. Neurosci Lett 123, 23-26.
30. Pazos, A., Probst, A. and Palacios, J.M. (1987) Serotonin receptors in the human brain - IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 21, 123-139.
31. 2 receptors in senile dementia of the Alzheimer type. Neurosci Lett 44, 47-51.
32. Robinson, D.S. (1993) Serotonin receptor subtypes and affective disorders. Clin Neuropharmacol 16 (Suppl. 3), S1-S5.
33. Roth, B.L. and Meltzer, H.Y. (1995) The role of serotonin in schizophrenia. In: Bloom, F.E. and Kupfer, D.J. (Eds.), Psychopharmacology, the Fourth Generation of Progress. Raven Press, New York, pp. 1215-1227.
34. 18F]altanserin: Results in young normal controls. J Cereb Blood Flow Metab 15, 787-797.
35. Schotte, A., Maloteaux, J.M. and Laduron, P.M. (1983) Characterization and regional distribution of serotonin S2-receptors in human brain. Brain Res 276, 231-235.
36. Shih, J.C and Young, H. (1978) The alteration of serotonin binding sites in aged human brain. Life Sci 23, 1441-1448.
37. Sparks, D.L. (1989) Aging and Alzheimer's disease. Altered cortical serotonergic binding. Arch Neurol 46, 138-140.
38. Van Peer, A., Woestenborghs, R., Embrechts, L. and Heykants, J. (1986) Pharmacokinetic approach to equilibrium between ketanserin and ketanserin-ol. Eur J Clin Pharmacol 31, 339-342.
39. 11C]-methyl)-2-Br-LSD. Synapse 1, 393-398.
40. Wong, D.F., Wagner, H.N., Dannals, R.F., Links, J.M., Frost, J.J., Ravert, H.T., Wilson, A.A., Rosenbaum, A.E., Gjedde, A., Douglas, K.H., Petronis, J.D., Folstein, M.F., Thomas Young, J.K., Burns, H.D. and Kuhar, M.J. (1984) Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science 226, 1393-1396.